Dr. Jeffrey Conn is a pharmacologist, a Professor of Pharmacology, and the Lee E. Limbird Chair in Pharmacology at Vanderbilt University. Dr. Conn’s research interests focus on the discovery of novel small molecule ligands for specific ion channels, receptors, and neurotransmitter transporters that can be used to probe pathways in the central nervous system and provide advances in developing novel treatments for neuropsychiatric and neurodegenerative diseases, including Alzheimer’s disease. Dr. Conn is a member of the Internal Advisory Committee and an investigator in the Vanderbilt Alzheimer’s Disease Research Center. He is also a member of the training faculty for the Vanderbilt Interdisciplinary Training Program in Alzheimer’s Disease (T32).
Dr. Conn completed his doctoral degree in pharmacology at Vanderbilt University and a postdoctoral fellowship in neurophysiology at Yale University. He joined the Vanderbilt faculty in 2003.